These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Maintaining urinary catheters: What does the evidence say? Seckel MA Nursing; 2013 Feb; 43(2):63-5. PubMed ID: 23353917 [No Abstract] [Full Text] [Related]
24. Feedback to nursing staff as an intervention to reduce catheter-associated urinary tract infections. Goetz AM; Kedzuf S; Wagener M; Muder RR Am J Infect Control; 1999 Oct; 27(5):402-4. PubMed ID: 10511486 [TBL] [Abstract][Full Text] [Related]
25. Initial inappropriate urinary catheters use in a tertiary-care center: incidence, risk factors, and outcomes. Apisarnthanarak A; Rutjanawech S; Wichansawakun S; Ratanabunjerdkul H; Patthranitima P; Thongphubeth K; Suwannakin A; Warren DK; Fraser VJ Am J Infect Control; 2007 Nov; 35(9):594-9. PubMed ID: 17980238 [TBL] [Abstract][Full Text] [Related]
26. Control of the duration of urinary catheterization: impact on catheter-associated urinary tract infection. Crouzet J; Bertrand X; Venier AG; Badoz M; Husson C; Talon D J Hosp Infect; 2007 Nov; 67(3):253-7. PubMed ID: 17949851 [TBL] [Abstract][Full Text] [Related]
27. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Bologna RA; Tu LM; Polansky M; Fraimow HD; Gordon DA; Whitmore KE Urology; 1999 Dec; 54(6):982-7. PubMed ID: 10604694 [TBL] [Abstract][Full Text] [Related]
28. Reduced rates of hospital-acquired UTI in medical patients. Prevalence surveys indicate effect of active infection control programmes. Christensen M; Jepsen OB J Hosp Infect; 2001 Jan; 47(1):36-40. PubMed ID: 11161896 [TBL] [Abstract][Full Text] [Related]
29. [Clinical study on efficacy of a Foley catheter coated with silver-protein in prevention of urinary tract infections]. Takeuchi H; Hida S; Yoshida O; Ueda T Hinyokika Kiyo; 1993 Mar; 39(3):293-8. PubMed ID: 8506804 [TBL] [Abstract][Full Text] [Related]
30. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. Al-Habdan I; Sadat-Ali M; Corea JR; Al-Othman A; Kamal BA; Shriyan DS Int Surg; 2003; 88(3):152-4. PubMed ID: 14584770 [TBL] [Abstract][Full Text] [Related]
31. Hospital-acquired catheter-associated urinary tract infection: documentation and coding issues may reduce financial impact of Medicare's new payment policy. Meddings J; Saint S; McMahon LF Infect Control Hosp Epidemiol; 2010 Jun; 31(6):627-33. PubMed ID: 20426577 [TBL] [Abstract][Full Text] [Related]
37. [Clinical study of Silver Lubricath Foley catheter]. Nakada J; Kawahara M; Onodera S; Oishi Y Hinyokika Kiyo; 1996 Jun; 42(6):433-8. PubMed ID: 8741298 [TBL] [Abstract][Full Text] [Related]
38. [Analysis of the risk factors in nosocomial urinary tract infections and effect of urinary catheter use on distribution of the causative agents]. Erben N; Alpat SN; Kartal ED; Ozgüneş I; Usluer G Mikrobiyol Bul; 2009 Jan; 43(1):77-82. PubMed ID: 19334383 [TBL] [Abstract][Full Text] [Related]
39. Not paying for catheter-associated urinary tract infections: more difficult than it seems? Clark RE; Clements KM Med Care; 2014 Jun; 52(6):479-81. PubMed ID: 24824534 [No Abstract] [Full Text] [Related]
40. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Tambyah PA; Knasinski V; Maki DG Infect Control Hosp Epidemiol; 2002 Jan; 23(1):27-31. PubMed ID: 11868889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]